Galectin Therapeutics (GALT) Net Cash Flow Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 453.08% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -125.22% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 53.46% |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - | 53.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53.13% |
| Dec 31, 2025 | 151.50% |
| Sep 30, 2025 | -253.27% |
| Jun 30, 2025 | 209.89% |
| Mar 31, 2025 | -265.27% |
| Dec 31, 2024 | -326.41% |
| Sep 30, 2024 | -39.98% |
| Jun 30, 2024 | 1,123.35% |
| Mar 31, 2024 | -165.45% |
| Dec 31, 2023 | 90.62% |
| Sep 30, 2023 | 128.70% |
| Jun 30, 2023 | 102.25% |
| Mar 31, 2023 | 90.14% |
| Dec 31, 2022 | -9.42% |
| Sep 30, 2022 | -266.87% |
| Jun 30, 2022 | -168.54% |
| Mar 31, 2022 | -26.01% |
| Dec 31, 2021 | 156.30% |
| Sep 30, 2021 | 160.91% |
| Jun 30, 2021 | 523.36% |
| Mar 31, 2021 | -53.71% |
| Dec 31, 2020 | -89.50% |
| Sep 30, 2020 | -381.36% |
| Jun 30, 2020 | -105.68% |
| Mar 31, 2020 | -224.12% |
| Dec 31, 2019 | -51.73% |
| Sep 30, 2019 | -372.58% |
| Jun 30, 2019 | 592.44% |
| Mar 31, 2019 | -237.01% |
| Dec 31, 2018 | 51.78% |
| Sep 30, 2018 | 83.36% |
| Jun 30, 2018 | 244.10% |
| Mar 31, 2018 | 154.42% |
| Dec 31, 2017 | -460.26% |
| Sep 30, 2017 | -11.57% |
| Jun 30, 2017 | 2.02% |
| Mar 31, 2017 | 50.77% |
| Dec 31, 2016 | -115.40% |
| Sep 30, 2016 | 61.45% |
| Jun 30, 2016 | -54.34% |
| Mar 31, 2016 | -1,679.19% |
| Dec 31, 2015 | 318.38% |
| Sep 30, 2015 | -56.52% |
| Jun 30, 2015 | -37.59% |
| Mar 31, 2015 | -99.15% |
| Dec 31, 2014 | -367.83% |
| Sep 30, 2014 | -169.80% |
| Jun 30, 2014 | -13.13% |
| Mar 31, 2014 | 1,212.75% |
| Dec 31, 2013 | 145.66% |
| Sep 30, 2013 | 322.03% |
| Jun 30, 2013 | 12.13% |
| Mar 31, 2013 | -126.31% |
| Dec 31, 2012 | -9.57% |
| Sep 30, 2012 | -5,097.50% |
| Jun 30, 2012 | -309.80% |
| Mar 31, 2012 | 743.61% |
| Dec 31, 2011 | -150.28% |
| Sep 30, 2011 | 18.37% |